Related Experiment Video

Updated: May 17, 2026

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

Efficiency of interleukin-1 blockade in refractory delayed-pressure urticaria

Cedric Lenormand, Dan Lipsker

    Annals of Internal Medicine
    |October 17, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions08:40

    An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

    Published on: March 14, 2016

    Related Concept Videos

    Antiasthma Drugs: Leukotriene Modifiers01:19

    Antiasthma Drugs: Leukotriene Modifiers

    Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
    Leukotriene modifiers work through two distinct mechanisms: